-+ 0.00%
-+ 0.00%
-+ 0.00%

MSD's stock price rose 3% as its partner Collumbott announced positive results in Coruida's key lung cancer research.

Zhitongcaijing·07/15/2026 13:41:14
Listen to the news
MSD's stock price rose 3% as its partner Collumbott announced positive results in Coruida's key lung cancer research.